extract: 2025-06-01-value-in-health-comprehensive-semaglutide-medicare-economics
- Factual accuracy — The claims are factually correct, and the new evidence supports the existing claims by providing specific economic modeling data.
- Intra-PR duplicates — There…
extract: 2025-05-01-nejm-semaglutide-mash-phase3-liver
- Factual accuracy — The claims appear factually correct, supported by the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is distinct…
extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd
- Factual accuracy — The claims and entities appear factually correct based on the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence…
extract: 2024-07-18-futardio-proposal-enhancing-the-deans-list-dao-economic-model
Approved (post-rebase re-approval).
extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes
- Factual accuracy — The claims are factually correct, supported by the provided evidence from the SELECT and FLOW trials.
- Intra-PR duplicates — There are no intra-PR duplicates;…
extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
Here's my review of the PR:
- Factual accuracy — The claims are factually correct, supported by the provided McKinsey source.
- Intra-PR duplicates — There are no intra-PR…
extract: 2026-03-01-pudgypenguins-retail-distribution-2026-update
Approved (post-rebase re-approval).